UR9 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Clinuvel Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 5.488 EUR

Market Cap: €828.3m

C	Clinuvel Pharmaceuticals Ltd XMUN:UR9	AU
G	Greencore Group PLC F:GCG	IE
L	Lloyds Banking Group PLC SWB:LLD	UK

Profitability Summary

Clinuvel Pharmaceuticals Ltd's profitability score is 76/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

95%

Strong 3Y Average Gross Margin

97%

Declining Gross Margin

102% > 95%

Exceptional Operating Margin

45%

Strong 3Y Average Operating Margin

53%

Declining Operating Margin

60% > 45%

Exceptional Net Margin

34%

Strong 3Y Average Net Margin

38%

Declining Net Margin

37% > 34%

Exceptional Free Cash Flow Margin

42%

Strong 3Y Average Free Cash Flow Margin

39%

Declining Free Cash Flow Margin

59% > 42%

Positive ROE

14%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

110%

Declining ROIC

200% > 108%

View All

Hide

Collapse

76 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.